Solitary Fibrous Tumor Treatment Market: Introduction

According to the report, the global solitary fibrous tumor treatment market was valued at
US$ 36.5 Mn in 2020 and is projected to expand at a CAGR of 4.5% from 2021 to 2031.
Solitary fibrous tumor (SFT) is a rare tumor of mesenchymal origin that accounts for less
than 2% of all soft tissue masses. Initially identified in the pleura, SFT has been identified in
multiple anatomic locations and can arise anywhere in the body. These tumors occur
equally in both men and women, most frequently in the 6th and 7th decades of life.
Request a PDF Brochure
- https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37022
Improved Diagnostic Procedures to Drive Global Market

In the past few decades, sustained advances through research & technology have led to
more reliable methods for differentiating this distinct soft tissue tumor. Advances,
specifically in immunohistochemistry and molecular diagnostics, have identified CD34 as the
most consistent marker in solitary fibrous tumor. More recently, the discovery of the NAB2-
STAT6 fusion gene has led to more precise diagnosis of solitary fibrous tumor. Hence,
improvement and new development of diagnostic procedures are anticipated to drive the
global solitary fibrous tumor treatment market.

Request for Analysis of COVID19 Impact on Solitary Fibrous Tumor Treatment Market-
https://www.transparencymarketresearch.com/sample/sample.php?
flag=covid19&rep_id=37022
High Cost of Treatment to Hamper Global Market

Several studies have suggested that people with rare diseases face higher healthcare costs
than those with common diseases. Solitary fibrous tumor is a very rare disease. Treatment
involves surgery and therapies such as radiation therapy and chemotherapy. However, high
cost of therapies and other immunotherapies is expected to deter patients from availing
these treatments.

Request for Custom Research -

https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=37022
Surgery to be Remain Treatment Method

The global solitary fibrous tumor treatment market has been segmented based on
treatment and end-user. In terms of treatment, the global solitary fibrous tumor market has
been classified into surgery, radiation therapy, and adjuvant chemotherapy. The surgery
segment is likely to account for major share of the global market by 2031, due to increase in
demand for surgery, as surgical management has been the mainstay treatment for solitary
fibrous tumor.

Hospitals to be Key End-user

In terms of end-user, the global solitary fibrous tumor treatment market has been divided
into hospitals, ambulatory surgical centers, and others. The hospitals segment is projected
to expand at a high CAGR during the forecast period due to rise in patient preference for all
types of treatment facility under one roof.
Buy now Solitary Fibrous Tumor Treatment Market Report -
https://www.transparencymarketresearch.com/checkout.php?rep_id=37022&ltype=S
North America to Dominate Global Market

The global solitary fibrous tumor treatment market has been segmented into five major
regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North
America dominated the global solitary fibrous tumor treatment market in 2020, followed by
Europe. North America accounted for major share of the global solitary fibrous tumor
treatment market in 2020 due to high awareness and increase in demand for disease risk
assessment services for cancer treatment.

The solitary fibrous tumor treatment market in Asia Pacific is projected to expand at a high
CAGR from 2021 to 2031. Rise in number of patients, high healthcare expenditure, and
geographic expansion by major players, especially in China and India, are anticipated to
drive the solitary fibrous tumor treatment market in the region.

Competition Landscape

The report also presents profiles of leading players in the global solitary fibrous tumor
treatment market. These include Pfizer, Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and
Company, Bayer AG, and Novartis AG.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/increasing-adoption-of-targeted-cancer-
therapies-to-propel-oncolytic-virus-immunotherapy-market-says-tmr-301347104.html
https://www.prnewswire.com/news-releases/rise-in-entry-of-various-companies-launch-of-
new-apis-incidence-of-diseases-to-drive-active-pharmaceutical-ingredients-api-market-
opines-tmr-301354346.html
https://www.prnewswire.com/news-releases/rising-popularity-of-automatic-cleaning-
process-creates-significant-expansion-avenues-in-medical-device-cleaning-market-states-
tmr-301358916.html
About Us

Transparency Market Research (TMR) is a market intelligence company, providing global

business information reports and services. Our exclusive blend of quantitative forecasting
and trends analysis provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants, use proprietary data
sources and various tools and techniques to gather, and analyze information. Our business
offerings represent the latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals,
chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and
technology. These reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology, TMR’s syndicated
reports strive to provide clients to serve their overall research requirement.
Contact

90 State Street, Suite 700

Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com